Latest Press Releases Sep 27 2022 Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022 Read More Sep 08 2022 Vertex Appoints Jonathan Biller as Chief Legal Officer Read More Sep 02 2022 Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months Read More Aug 31 2022 Vertex to Participate in the Wells Fargo Healthcare Conference on Friday, September 9 Read More Aug 04 2022 Vertex Reports Second Quarter 2022 Financial Results Read More Jul 22 2022 Vertex Advances VX-548 in Acute and Neuropathic Pain Read More Load More Recent Media Library Items View All Date - Any -20212022 Tags Download LibraryImages Inclusion, Diversity and Equity at Vertex Fact Sheet Download 3 MB Date - Any -20212022 Tags Download LibraryImages Reshma Kewalramani, M.D. Chief Executive Officer and President Download 10 MB Date - Any -20212022 Tags Download LibraryImages Vertex International Headquarters Paddington – Lobby Padding reception entrance Download 915 KB Date - Any -20212022 Tags Download LibraryImages Vertex Logo with Tagline Download 2 MB | 2951 x 1952 Mediainfo@VRTX.com
Sep 27 2022 Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022 Read More
Sep 02 2022 Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months Read More
Aug 31 2022 Vertex to Participate in the Wells Fargo Healthcare Conference on Friday, September 9 Read More
